Sage Therapeutics, Inc.
SAGE
$8.04
$0.1752.23%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -400.67M | -337.59M | -445.67M | -503.14M | -541.49M |
| Total Depreciation and Amortization | 1.03M | 1.31M | 1.39M | 1.41M | 1.39M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 47.68M | 58.41M | 70.04M | 62.19M | 66.90M |
| Change in Net Operating Assets | 84.76M | -42.28M | 589.00K | 14.82M | -67.38M |
| Cash from Operations | -267.19M | -320.15M | -373.65M | -424.74M | -540.59M |
| Capital Expenditure | -- | 112.00K | -216.00K | -328.00K | -553.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 266.68M | 262.05M | 341.72M | 387.81M | 443.47M |
| Cash from Investing | 266.68M | 262.17M | 341.50M | 387.48M | 442.91M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 11.18M | 11.18M | 12.52M | 5.19M | 6.93M |
| Repurchase of Common Stock | -404.00K | -664.00K | -269.00K | -276.00K | -903.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -117.00K | -117.00K | -117.00K | -- | -- |
| Cash from Financing | 10.66M | 10.40M | 12.14M | 4.91M | 6.03M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.15M | -47.59M | -20.02M | -32.34M | -91.65M |
